Prions are proteins that can undergo a heritable conformational change to an aggregated amyloid-like state, which is then transmitted to other similar molecules. Ure2, the nitrogen metabolism regulation factor of Saccharomyces cerevisiae, shows prion properties in vivo and forms amyloid fibrils in vitro. Ure2 consists of an N-terminal prion-inducing domain and a C-terminal functional domain. Previous studies have shown that mutations affecting the prion properties of Ure2 are not restricted to the N-terminal prion domain: the deletion of residues 151-158 in the C-domain increases the in vivo prion-inducing propensity of Ure2. Here, we characterized this mutant in vitro and found that the 151-158 deletion has minimal effect on the thermodynamic stability or folding properties of the protein. However, deletion of residues 151 -158 accelerates the nucleation, growth and fragmentation of amyloid-like aggregates in vitro, and the aggregates formed are able to seed formation of fibrils of the wild-type protein. In addition, the absence of 151 -158 was found to disrupt the inhibitory effect of the Hsp40 chaperone Ydj1 on Ure2 fibril formation. These results suggest that the enhanced in vivo prion-inducing ability of the 151 -158 deletion mutant is due to its enhanced ability to generate prion seeds.
Introduction
Ure2 is the protein determinant of the [URE3] prion state in Saccharomyces cerevisiae. Analogous to the properties of the mammalian prion protein, Ure2 shows the ability to convey a heritable phenotype change by undergoing a structural change at the protein level to an amyloid-like form (Wickner, 1994; Masison and Wickner, 1995; Lian et al., 2006; Perrett and Jones, 2008) . Ure2 functions as a nitrogen metabolism regulation factor in Saccharomyces cerevisiae by interacting with the transcription factor Gln3, allowing control of nitrogen catabolite repression and blocking the uptake of poor nitrogen sources in the presence of a good nitrogen source (Coschigano and Magasanik, 1991; Cooper, 2002) ; this function is inactivated upon transformation of Ure2 to the prion state. Ure2 is a 354-amino acid homodimeric protein consisting of a relatively flexible N-terminal domain and a globular C-terminal domain (Perrett et al., 1999; Thual et al., 1999; Bousset et al., 2001a; Umland et al., 2001) . The unstructured N-terminal domain ( 90 amino acids) is required for both the prion properties in vivo (Masison and Wickner, 1995) and amyloid formation in vitro (Taylor et al., 1999; Thual et al., 2001; Jiang et al., 2004) , and is thus referred to as the prion-inducing domain (PrD). The C-terminal domain shows structural similarity to the glutathione S-transferase superfamily (Bousset et al., 2001a; Umland et al., 2001) and is both necessary and sufficient for its in vivo nitrogen regulatory function (Coschigano and Magasanik, 1991; Cooper, 2002) . The C-terminal domain of Ure2 binds glutathione (GSH) (Bousset et al., 2001b) and shows GSH-dependent peroxidase (GPx) (Bai et al., 2004) and glutaredoxin (GRX) activities (Zhang and Perrett, 2009) .
Protein sequence analysis of Ure2 has demonstrated that the PrD is generally divergent and rich in Asn and Gln residues, but contains a relatively conserved region, corresponding to residues 10-40, which contains normal random sequence . Studies have shown that deletions of Asn/Gln repeats in the PrD reduce the prion inducing ability in vivo and the amyloid formation in vitro of Ure2 (Maddelein and Wickner, 1999; Jiang et al., 2004) ; deletion of the normal random sequence (residues 15-42) also results in decreased fibril formation of Ure2 in vitro (Jiang et al., 2004) . In contrast to the importance of the PrD in the prion induction and amyloid formation of Ure2, the deletion of the PrD has no detectable effect on the dimeric structure, thermodynamic stability and folding kinetics of Ure2 under a wide range of conditions (Perrett et al., 1999; Thual et al., 2001; Zhou et al., 2001; Galani et al., 2002; Zhu et al., 2003a,b) . Amyloid-like fibrils of Ure2 are thought to form by conversion of the PrD to a parallel in-register b-sheet structure (Baxa et al., 2005 (Baxa et al., , 2007 surrounded by the C-terminal domains in a native-like conformation, which is suggested by both our previous studies in which Ure2 maintains native-like activity in the fibrillar form (Bai et al., 2004; Zhang et al., 2008; Zhang and Perrett, 2009) and other studies in which heterologous proteins fused to the PrD retain their enzymatic activity in amyloid fibrils (Baxa et al., 2002) . Therefore, the loss of regulatory function of Ure2 associated with prion formation is likely to be due to a steric effect rather than the loss of native structure.
However, previous studies have suggested the involvement of the C-terminal region of Ure2 in its prion properties, suggesting interplay between the roles of the PrD and the † These authors contributed equally to this work. C-terminal region. A number of deletions in the C-terminal region have been found to increase or decrease the in vivo prion-inducing propensity of Ure2 when overexpressed in a wild-type (WT) background: deletion of residues 221-227 decreases prion induction (Maddelein and Wickner, 1999) , and the deletion of 151 -158 or 348-354 increases the rate of prion induction (Masison and Wickner, 1995) . Interestingly, while deletion of residues 1 -65 removes prion inducing ability, the combined deletion of this and the regions 151-158 and 348 -354 produces a fragment that can once again induce prion formation (Maddelein and Wickner, 1999) . Studies on the structural and folding properties of these mutants may yield important insight into the molecular mechanism of prion induction and propagation.
A key feature of prion disease is protein misfolding leading to formation of amyloid-like aggregates. Studying the relationship between protein folding and amyloid formation is a prerequisite to elucidating the molecular mechanism of prion formation. In this study, we constructed a C-terminal mutant of Ure2 lacking residues 151-158, which we term D151-158 Ure2, as well as further mutants with additional deletions within the PrD (Fig. 1) . We then characterized the equilibrium denaturation and amyloid formation of these mutants, with the purpose of elucidating the mechanism by which the deletion of the C-terminal residues 151-158 increases the in vivo prion inducing ability of Ure2 and thus providing insight into the relationship between the molecular mechanism of prion formation of Ure2 and its folding properties.
Materials and methods

Materials
GdmCl, Tris and ThT were obtained from Sigma. Other chemical regents were local products of analytical grade. Twice deionized water was used throughout. Solutions were made volumetrically. Concentrations of GdmCl solutions were confirmed by use of an Abbe refractometer.
Mutant construction and protein purification
All mutants of Ure2 were obtained by PCR using a synthetic WT URE2 gene as a template (Perrett et al., 1999) and confirmed by DNA sequencing of the entire gene. Ure2 and mutants were expressed in Escherichia coli and purified as described previously (Perrett et al., 1999) except that a French press was used to lyse cells in place of sonication. Proteins were stored at 2808C and defrosted in a 258C water bath immediately prior to use. Samples were prepared in 50 mM Tris -HCl buffer, pH 8.4 containing 0.2 M NaCl unless stated otherwise and centrifuged at 18 000 g for 30 min at 48C to remove any aggregated protein before experiments. The protein concentration in terms of monomers was measured by absorbance at 280 nm using the calculated extinction coefficient of 48 200 M 21 cm 21 (Perrett et al., 1999) . Ydj1 was purified as described previously (Lian et al., 2007) .
Equilibrium denaturation measurements
The equilibrium denaturation of Ure2 or mutants was investigated by following the changes in intrinsic tryptophan fluorescence as described previously (Zhu et al., 2003b) . D15-42 Ure2 was used as a pseudo WT, due to its enhanced solubility and reversibility of folding, as described previously (Perrett et al., 1999; Galani et al., 2002; Zhu et al., 2003b) . Data analysis and curve fitting were performed as described (Zhu et al., 2003b) . The methods for fluorescence measurements and data analysis are briefly outlined below.
Sample preparation. Equilibrium denaturation curves were measured in 50 mM Tris -HCl buffer, pH 8.4, containing 0.2 M NaCl, conditions found to provide optimum solubility and reversibility of folding, particularly for the full-length Ure2 or D15 -42 Ure2 (Perrett et al., 1999) . GdmCl was chosen as the denaturant and 8 M GdmCl was prepared in the same buffer. Samples denatured in different concentrations of GdmCl were prepared and allowed to equilibrate overnight at 258C before taking measurements.
Intrinsic fluorescence measurements. All measurements were performed at 258C using a Hitachi F-4500 or Shimadzu RF-5301PC spectrofluorimeter. Excitation was at 280 nm and emission spectra were measured between 300 and 400 nm. The maximum change in fluorescence intensity upon denaturation was observed at 327 nm and under apparent two-state conditions, an isosbestic point at 369 nm was observed (Perrett et al., 1999) . The denaturation curves were made by plotting the ratios of fluorescence intensity at 327 nm to that of 369 nm versus [GdmCl] after normalization. The final concentration of the protein in terms of monomer in the denaturation samples ranged from 0.5 to 5 mM.
Data analysis of the equilibrium unfolding. The equilibrium denaturation curves were fitted to the model of three-state unfolding via a homodimeric intermediate (N 2 , I 2 , 2U) as described in detail previously (Zhu et al., 2003b) . The model is briefly outlined below. It was shown previously from detailed study over a range of protein concentrations and other experimental conditions that even where the denaturation transition appears two-state for Ure2, a more accurate estimate of the thermodynamic stability is obtained for this protein by fitting the apparent two-state transition to a three-state model (Zhu et al., 2003b) . This is achievable because the amplitude of the fluorescence signal for the intermediate state is routinely used as a fixed parameter (see below). Non-linear least-squares fitting of the data was carried out using the regression wizard of the SigmaPlot software.
The amplitude of the spectroscopic signal determined at each denaturant concentration is assumed to be a linear combination of the fractional contribution from each species:
where y N , y U , m N and m U are the intercepts and slopes of the initial and final baselines, respectively; y I is the amplitude of the signal for the intermediate state, which is assumed not to vary with [GdmCl] in order to minimize the number of parameters in the fit (Grimsley et al., 1997) and f N , f I and f U are the fraction of native, intermediate and denatured states, respectively.
The equilibrium constants for the two transitions are given by
From these relationships, f N , f I and f U can be solved and expressed using K 1 , K 2 and C as shown below:
The free energy for unfolding, DG U ¼ 2RT lnK, shows a linear relationship with the denaturant concentration (Tanford, 1968 )
where m is the denaturant dependence (or slope) of the transition and DG U (H 2 O) is the free energy of unfolding in the absence of denaturant. Assuming the two transitions are distinct, the midpoint of the first transition occurs when
Similarly, the midpoint of the second transition occurs when
where m 1 and m 2 are the slopes, and (2), (5) and (7). Thus, the free energy change of the first and second transition can be obtained from equations (4) and (6), respectively, and the overall stability of the protein according to this model is obtained from:
ThT binding assay
The kinetics of amyloid formation of Ure2 and mutants was monitored using the ThT binding assay as described previously (Zhu et al., 2003b; Jiang et al., 2004) . Briefly, a volume of 300 ml Ure2 or its mutant was pipetted into a 2 ml microcentrifuge tube and a 3 mm diameter glass sphere (Fisher) was added. NaN 3 (0.02% w/v) was added to prevent bacterial growth. The tubes were incubated at 378C or 258C, as indicated, with agitation at 200 rpm. Alternatively, proteins were incubated at 48C without agitation. At regular time intervals, 10 ml aliquots were removed from the incubated mixture and assayed for ThT binding. For each sample, the intensity of ThT fluorescence at 485 nm excited by 450 nm was measured on a Hitachi F-4500 or Shimadzu RF-5301PC spectrofluorimeter. Samples were incubated in parallel whenever possible.
EM imaging
The morphology of fibrils was confirmed by electron microscopy (EM). A 10 ml aliquot of protein was adsorbed onto a glow-discharged carbon support film for 1 min and washed twice with 10 ml distilled water. Excess solution was blotted off with a filter paper. Specimens were negatively stained with uranyl acetate (2%, w/v) and examined on a Philips Tecnai 20 electron microscope. Images were collected by CCD camera.
Cross-seeding experiments
Seed preparation. WT Ure2 or D151-158 Ure2 was incubated at a concentration of 40 mM at 48C in 50 mM
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Tris -HCl, pH 8.4, 200 mM NaCl for at least 10 days, by which time polymerization was complete as measured by ThT assay. Mature fibrils were then sonicated using a probe sonicator (Sonics and Materials VCX750) for 5 s (22% energy) in order to produce the seeds used in the solution seeding experiments.
Cross-seeding. Twenty micromolar WT Ure2 or D151-158 Ure2 protein was incubated with a series of concentrations (0, 1, 2, 4, 7 and 10%) of pre-prepared WT Ure2 or D151 -158 Ure2 seeds at 48C without agitation in 50 mM Tris -HCl, pH 8.4, 200 mM NaCl. The kinetics of fibril formation was monitored by the ThT assay as described above. 
where the constants are fixed by the initial conditions:
where P 0 is the number and F 0 ¼ P 0 L 0 the mass concentration of seed fibrils at t ¼ 0, which are related through L 0 , the average number of molecular units in a seed fibril; m 0 is the initial concentration of soluble Ure2p; and k þ is the rate constant for fibril elongation. The single effective rate constant k describes the rate of growth of the fibril population through the concerted action of fragmentation and elongation:
where k 2 is the rate constant for fragmentation. This allows two free global parameters to be determined, defined as
, which can be obtained through fitting the kinetics of fibril formation. In order to remove the issue of comparing different batches of protein seeds, and also to circumvent the difficulty of defining the actual value of L 0 , cross-seeding was used and comparison was carried out using ratios of the rate constants (Y.Q.W., A. Buell, X.Y. Wang, M. Welland, C.M. Dobson, T.P.J. Knowles, and S.P., submitted for publication). This means that L 0 is constant within a given cross-seeding experiment and the L 0 term cancels out. The ratios of the elongation rates (r þ ) or breakage rates (r 2 ) for mutant and WT Ure2 were then calculated for both types of seeds as follows: In order to compare the effects associated with the nature of the seed, we introduce the ratio:
A value of h + ¼ 1 indicates that the nature of the seed does not affect the rate constants for elongation (þ) or breakage (2).
Results and discussion
Deletion of residues 151 -158 does not affect the secondary structure of Ure2
As shown in Fig. 2 , WT Ure2 and D151 -158 Ure2 showed very similar far-UV CD spectra, indicating that the deletion of residues 151 -158 does not substantially disrupt the overall helical secondary structural content of Ure2.
The deletion of residues 151-158 does not alter the thermodynamic stability of the protein
As mentioned above, understanding the stability and folding properties of prion proteins is a prerequisite to elucidate the molecular mechanism of prion formation. Identification and characterization of folding intermediates is a crucial step in evaluating plausible mechanisms for prion conversion and propagation. The folding properties of Ure2 have been studied in detail (Perrett et al., 1999; Thual et al., 2001; Galani et al., 2002; Zhu et al., 2003a,b) . Equilibrium denaturation indicates that Ure2 undergoes a three-state unfolding process via a dimeric intermediate (Zhu et al., 2003b) . Here, we examined the effect of the deletion of residues 151-158 on the stability of Ure2. We made use of a variant of Ure2, D15-42 Ure2 as a pseudo WT, due to its exceptional solubility and identical folding behavior to WT Ure2 (Perrett et al., 1999; Galani et al., 2002; Zhu et al., 2003b) . A direct role of residues 15-42 in amyloid formation has been proposed and would explain the increased solubility of the D15-42 Ure2 protein (Jiang et al., 2004) . Similar to D15-42 Ure2, the equilibrium denaturation of D151 -158 Ure2 showed a three-state unfolding transition (Fig. 3a) . The unfolding profile of D151 -158 Ure2 involved two transitions: the first transition did not show dependence on the protein concentration and corresponds to partial unfolding of the protein, while the second transition showed protein concentration dependence and corresponds to the dissociation and unfolding of the dimeric intermediate (Fig. 3a) , as found previously for the WT protein and its N-terminal deletion mutants (Zhu et al., 2003b) . The thermodynamic parameters were obtained by fitting the denaturation curves of D151-158 Ure2 at different concentrations to a three-state model (see Materials and Methods section and Table I ). Compared with D15 -42 Ure2, D151 -158 Ure2 showed lower midpoints for both transitions, [GdmCl] 1/2,1 and [GdmCl] 1/2,2 ( Fig. 3b and Table I ). However, this was accompanied by a greater slope (m-value), particularly for the first transition, with the result that the calculated apparent free energy changes for the two individual transitions, DG 1 (H 2 O) and DG 2 (H 2 O), and for the overall unfolding process, DG U (H 2 O), are the same within error for the pseudo WT and for the D151 -158 mutant (Table I) .
The effect of the PrD on the stability of D151 -158 Ure2 was also examined. As was found previously for the WT protein (Perrett et al., 1999; Thual et al., 2001; Galani et al., 2002; Zhu et al., 2003a,b) , deletion of parts of the PrD (to produce the double-deletion mutants D1-14D151-158 Ure2, D15-42D151 -158 Ure2 or D1-42D151-158 Ure2, Fig. 1a ) had no effect on the stability or folding behavior of the protein (Fig. 3c and Table I ).
Taken together, these results indicate that the deletion of residues 151 -158 has no effect on the stability of the Ure2 protein or its equilibrium denaturation behavior, suggesting that the altered prion-inducing propensity observed for the D151 -158 mutant in vivo (Masison and Wickner, 1995; Maddelein and Wickner, 1999 ) is unlikely to be due to altered folding of the C-domain of the Ure2 protein.
Deletion of residues 151 -158 accelerates the rate of amyloid-like aggregation of Ure2 while deletions in the PrD modulate the kinetics and morphology of aggregation Fibrils formed in vitro bind ThT, a dye considered highly specific for amyloid, and emit specific fluorescence at 485 nm. Thus, ThT binding provides a convenient method to assay the kinetics of amyloid formation (LeVine, 1993) . Previous studies have demonstrated that the time course of Ure2 amyloid formation monitored by ThT binding shows a sigmoidal curve, representing a lag time corresponding to a nucleation process, an exponential elongation phase and a Deletion of residues 151-158 of Ure2 promotes prion seed formation plateau region (Schlumpberger et al., 2000; Bousset et al., 2002; Zhu et al., 2003b) . We have shown previously that for WT Ure2, the increase in ThT fluorescence correlates directly with the first appearance of fibrillar structures by atomic force microscopy (AFM) (Jiang et al., 2004) , and the ThT fluorescence signal is linearly proportional to the concentration of the Ure2 protein in fibrillar form (Y.Q.W., A. Buell, X.Y. Wang, M. Welland, C.M. Dobson, T.P.J. Knowles and S.P., submitted for publication). However, in the case of deletion mutants of Ure2, the degree of ThT fluorescence can be dramatically affected. In particular, deletion of the residues 15 -42 was found to dramatically reduce the ability of Ure2 to bind ThT, although the ability to form fibrils was maintained (Jiang et al., 2004) . Therefore, ThT binding results are best interpreted in combination with fibril imaging techniques such as AFM or EM.
Here, we found that compared with WT Ure2, the time course of D151-158 Ure2 amyloid formation showed a similar sigmoidal curve but with a shorter lag time (Fig. 4) . This suggests that the deletion of residues 151 -158 enhances the ability of Ure2 to form amyloid fibrils in vitro, which is consistent with the in vivo result that this deletion increases its prion inducing ability (Maddelein and Wickner, 1999) .
While D151 -158 Ure2 showed a higher ThT fluorescence intensity in the plateau region than WT, the additional deletion of residues 1 -14, 15-42 or 1 -42 of the PrD (to produce the double-deletion mutants D1-14D151-158 Ure2, D15 -42D151-158 Ure2 or D1-42D151 -158 Ure2) dramatically lowered the fluorescence intensity in the plateau phase (Fig. 4) . In the case of D1-14D151-158 Ure2, a sigmoidal shape to the curve was still detectible, allowing it to be seen that deletion of residues 1 -14 results in a significant increase in the lag time (Fig. 4) , as was also found previously for WT Ure2 (Jiang et al., 2004) . These results suggest that the PrD modulates the fibril formation of D151 -158 Ure2 in a similar way as it does for WT.
However, unlike the typical fibril morphology of WT Ure2 fibrils (Fig. 5a ), the morphology of fibrils formed from D151-158 Ure2 and D1-14D151-158 Ure2 observed by EM showed predominantly granular aggregates (Fig. 5b and c) . These granular aggregates apparently also contain ordered structure because they could bind to the dye ThT and emit fluorescence (LeVine, 1993) (Fig. 4) . Most interestingly, the further deletion of residues 15-42 restored the morphology Data of D15-42 Ure2 could only be fitted to a three-state model by using a fixed value for y I (of 0.43), in order to limit the number of fitting parameters, where y I is the normalized spectroscopic intensity of the intermediate. The value for 1 mM protein concentration is shown.
of the aggregates of D151-158 Ure2 to the well-formed fibrillar structures typically observed for WT Ure2 (Fig. 5d) or indeed for the mutant D15-42 Ure2 (Jiang et al., 2004) , although binding to ThT is lost in the D15-42 Ure2 mutants (Fig. 4) due to deletion of the hydrophobic region 15-42 (Jiang et al., 2004) .
D151-158 Ure2 formed fibrils with greater elongation and breakage rate constants than WT Ure2
The successful propagation of a prion depends on the capacity of the soluble protein to convert to the fibrillar form to promote the multiplication of prion seeds and their transmission to other cells. Not only the elongation rate but also the breakage rate of amyloid fibrils has been demonstrated to be crucial for prion propagation (Collins et al., 2004; Smith et al., 2006; Tanaka et al., 2006) . Consequently characterizing the kinetic parameters governing fibril growth proves to be very important. Here, we measured the kinetics of fibril growth of WT Ure2 and D151-158 Ure2 in order to shed light on the kinetics of prion assembly from a quantitative point of view. We analyzed fibril growth measurements using a master equation (Knowles et al., 2009 ) which includes the three key processes governing amyloid growth: nucleation, elongation and breakage. This picture includes three kinetic constants: the nucleation rate constant (k n ), the elongation rate constant (k þ ) and the breakage rate constant (k 2 ). In the presence of preformed seed fibrils, the lag time of the fibril formation can be circumvented, which is consistent with a nucleation mechanism (Taylor et al., 1999; Thual et al., 1999; Schlumpberger et al., 2000) , and soluble Ure2 will polymerize onto the end of existing seeds with a rate of k þ , which is generally found to be faster than spontaneous formation of nuclei (Jarrett and Lansbury, 1993) ; indeed under the conditions used here, even in the presence of a small concentration of preformed fibrils, the polymerization reaction reached completion before measurable polymerization took place in samples lacking seed fibrils (Fig. 6) . Therefore, in the presence of seed fibrils, the contribution to the overall reaction of spontaneous nucleation events can be neglected and only two constants (k þ , k 2 ) characteristic of the system are left. In order to ensure that the number of WT Ure2 and D151 -158 Ure2 fibril ends in different batches of seed are identical, we performed cross-seeding experiments such that the same WT Ure2 or D151 -158 Ure2 seed stock solution was used in a given experiment to seed solutions of both proteins. It was found that WT Ure2 and D151 -158 Ure2 could be seeded by each other (Fig. 6 ) and the kinetic parameters of fibril formation were obtained by fitting the data globally to an explicit analytical solution to the master equation of fibrillar growth (Knowles et al., 2009) . Then the ratios r + of the rate constants k + for growth reactions of WT Ure2 or D151 -158 Ure2 were calculated from the fitted kinetic parameters (see Materials and Methods section) and summarized in Table II . Regardless of which protein was used as the seed, the ratios of both the elongation and the breakage rate constants were significantly .1, indicating that fibrils grown from D151-158 Ure2 possess a higher elongation rate and breakage rate than those grown from WT Ure2, meaning that the D151-158 Ure2 fibrils grew and fragmented faster than those of WT. The larger elongation and breakage rates of D151 -158 Ure2 may contribute to its enhanced prion inducing ability in vivo. The nature of the protein seed was observed to have up to a 2-fold effect on the ratios of elongation and breakage rates (Table II) , suggesting that the elongation and breakage rates of fibrils formed by WT Ure2 or D151-158 Ure2 are dependent on both the nature of the seed and that of the soluble protein; this was also found for breakage rates of homologues of Ure2 from different species of yeast (Y.Q.W., A. Buell, X.Y. Wang, M. Welland, C.M. Dobson, T.P.J. Knowles and S.P., submitted for publication).
Deletion of residues 151 -158 disrupts the inhibitory effect of Ydj1 on amyloid-like aggregation of Ure2
Molecular chaperones play a crucial role in the cell by safeguarding proteins from misfolding and aggregation, particularly under conditions of stress, such as heat shock or disease (Walter and Buchner, 2002; Young et al., 2004) . Like other heat-shock proteins (Jones and Tuite, 2005) , Hsp40 members have been found to play a role in yeast prion propagation. Ydj1 from S. cerevisiae is a molecular chaperone of the type I Hsp40 family. Overexpression of Ydj1 results in the loss of the [URE3] prion (Moriyama et al., 2000) and also cures certain variants of another yeast prion et al., 2002) . Ydj1 has a specific effect on [URE3] that is not replicated by overexpression of other J-domain-containing proteins (Lian et al., 2007; Higurashi et al., 2008) , although overexpression of an isolated J-domain is sufficient to cause curing of [URE3] and a point mutation (H34Q) that disrupts functional interaction with Hsp70 also disrupts the curing effect on [URE3], suggesting that the effect of Ydj1 overexpression in vivo is mediated by Hsp70 (Higurashi et al., 2008) . Our previous studies have shown that in vitro Ydj1 inhibits Ure2 fibril formation by binding to the native state of Ure2, prior to the onset of oligomerization (Lian et al., 2007) . To ascertain whether the deletion of residues 151-158 affects the interactions between Ure2 and Ydj1, we examined the effect of Ydj1 on the fibril formation of D151-158 Ure2. (In order to facilitate comparison, we used a 2-fold higher concentration of WT Ure2 than Deletion of residues 151-158 of Ure2 promotes prion seed formation D151 -158 Ure2, so that the rates of fibril formation for the two proteins in the absence of chaperone were similar, and incubated each protein with or without an equimolar concentration of Ydj1.) As found previously (Lian et al., 2007) , the presence of Ydj1 significantly increases the lag time of the fibril formation of WT Ure2 (Fig. 7) . However, in comparison, the inhibitory effect of Ydj1 on the aggregation of D151 -158 Ure2 was significantly reduced (Fig. 7) . These results suggest that the deletion of residues 151-158 alters the interaction of Ydj1 with the native state of Ure2 and thus decreases the ability of Ydj1 to inhibit the fibril formation of Ure2 in vitro. While the in vivo significance of this result has yet to be ascertained, it does imply that deletion of residues 151-158 may affect the interaction of Ure2 with chaperones and other partner proteins.
Implications for the mechanism of prion formation
Recent studies have shown that mutations affecting the prion properties of Ure2 are not restricted to the N-terminal PrD. Deletion of residues 221-227, 151-158 or 348 -354 was found to decrease or increase the in vivo prion-inducing propensity of Ure2 when the mutant is overexpressed in a WT background, with D151-158 producing a 100-fold increase in the rate of induction compared to overexpression of WT 
The values shown represent the mean and the standard error derived from the global fit of the data (see Materials and Methods section), where (12)- (16)]. A value of r þ or r 2 . 1 means that the elongation or breakage rate, respectively, for the mutant protein is greater than for WT; a value of h þ or h 2 that deviates from unity indicates that the nature of the protein seed influences the elongation or breakage rate, respectively.
itself (Maddelein and Wickner, 1999) . Similarly, a series of point mutations that increase the rate of prion induction have been identified (Fernandez-Bellot et al., 2000) : a pair of mutations in the N-terminus (S10L and R17C) combined with a single mutation in the C-terminus (K127E) results in a 500-fold increase in the prion induction rate of Ure2; and a mutation pair (S10L/V271E) is 10 times more efficient than WT at inducing the [URE3] prion (Fernandez-Bellot et al., 2000) . The results of these mutagenesis studies imply not only the involvement of the C-terminal region in the mechanism of prion induction, but also that there is interplay between the N-terminal and C-terminal regions of the protein. In this study, we investigated the folding and fibril formation properties in vitro of D151 -158 Ure2, which shows enhanced rates of prion induction in vivo, in order to obtain insight into the molecular mechanism of prion induction and propagation of Ure2.
Various models have been proposed to describe the mechanism of amyloid or prion formation (Harper and Lansbury, 1997; Kelly, 2000) . In general, amyloidogenic proteins show a sigmoidal time-course for fibril formation and the lag time can be reduced or circumvented by the addition of preformed fibril seeds indicating that the process involves a nucleation step. A common feature of the various models is the involvement of partially folded (or misfolded) intermediate states, implying that the mechanism of amyloid or prion formation is related to the pathway by which the protein folds (or misfolds). Therefore, characterization of the folding behavior of prion proteins is an important step in elucidating the mechanism of prion formation. The equilibrium denaturation of Ure2 shows that Ure2 folds via a dimeric intermediate (Zhu et al., 2003b) and our previous studies on the conditions affecting the folding and amyloid formation of Ure2 have suggested that the formation of the Ure2 amyloid precursor involves at least partial unfolding of the native dimer (Zhu et al., 2003b) . Kinetic experiments detect population of two distinct intermediates during refolding of Ure2: a 'burst phase' intermediate formed within the dead-time of stopped-flow mixing and a dimeric intermediate (Galani et al., 2002) . The dimeric intermediate (I 2 ) is known to be on-pathway, and the burst phase intermediate is known to be monomeric (Perrett et al., 1999; Galani et al., 2002) . The relationship of the monomeric intermediate to the folding pathway is not certain, but conditions that favor population of the monomeric intermediate also favor aggregation (Perrett et al., 1999; Galani et al., 2002) . Here, we examined the effect of residues 151-158 on the folding properties of Ure2 in vitro and found that, similar to WT Ure2, D151-158 Ure2 shows a three-state denaturation process via a dimeric intermediate (Fig. 3) . However, compared with WT Ure2, the deletion of residues 151-158 did not cause any significant change in thermodynamic stability (Table I) . Further deletions of parts of the PrD showed no effect on the equilibrium unfolding of D151-158 Ure2, as was found previously for WT (Perrett et al., 1999; Zhu et al., 2003b) . Thus, it is unfortunate that in this case, nothing regarding the role of protein stability or the relative population of the various folding intermediates can be deduced. However, the results do indicate that in the case of D151 -158, its enhanced propensity to induce a prion state in vivo is not due to an alteration in propensity to unfold or populate folding intermediates.
Consistent with its enhanced prion-inducing ability in vivo, the deletion of residues 151-158 increased the fibril formation of Ure2 in vitro demonstrated by a significantly shortened lag time in the time-course of fibril formation monitored by the ThT assay (Fig. 4) . D151 -158 Ure2 tended to form granular aggregates rather than the typical amyloidlike fibrils formed by WT Ure2 (Fig. 5) . These spherical particles appear to be at least partially ordered because they could also bind to the amyloid-specific dye ThT and emit fluorescence. Importantly, the aggregates formed from WT Ure2 and D151 -158 Ure2 could be seeded by each other (Fig. 6 ), implying that they possess similar basic structures. Furthermore, this provides a mechanistic explanation for the observation that overexpression of D151 -158 Ure2 induces the [URE3] prion state in a WT background.
As for WT Ure2 (Jiang et al., 2004) , further deletions in the PrD decreased the fibril formation of D151-158 Ure2. The mechanism by which deletion of the normal random sequence region 15-42 restored the amyloid morphology of D151 -158 Ure2 (Fig. 5) is not yet understood and is worthy of further investigation. In addition to the faster nucleation rate of D151-158 Ure2 implied by the shorter lag time observed in un-seeded ThT assay curves (Fig. 4) , crossseeding experiments between WT Ure2 and D151-158 Ure2 showed greater elongation and breakage rate constants for the fibrils formed from D151-158 Ure2 compared to those formed from WT Ure2 (Fig. 6 and Table II) . These results potentially explain the mechanism by which the deletion of the 151-158 region increases the rate of prion induction by Ure2 overexpression in vivo, that is, by increasing both the rate of nucleation and the ease of propagation of prion seeds. Whether the D151-158 Ure2 protein itself can maintain the [URE3] prion state, or whether it merely seeds the WT protein to form [URE3], will require further in vivo experiments to ascertain.
